EphB4 is similarly over-expressed in head and neck cancers (100% of 37 cases examined) and knockout studies using siRNA and antisense both in vitro and importantly, in vivo, have demonstrated that EphB4 has an essential role in many processes that contribute to cancer cell survival and spread [16,17]. Here, EPHB4 is linked to cancer.